We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+13.11%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.02B
AUM Growth
+$31.2M
Cap. Flow
-$130M
Cap. Flow %
-6.43%
Top 10 Hldgs %
16.17%
Holding
2,969
New
1,707
Increased
193
Reduced
681
Closed
23

Top Buys

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$2.78M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$2.48M
3
CFR icon
Cullen/Frost Bankers
CFR
+$2.32M
4
BIVV
Bioverativ Inc. Common Stock
BIVV
+$2.17M
5
MAR icon
Marriott International
MAR
+$2.1M

Top Sells

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$61.8M
2
BND icon
Vanguard Total Bond Market
BND
+$34M
3
TTE icon
TotalEnergies
TTE
+$32.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$6.15M
5
IDXX icon
Idexx Laboratories
IDXX
+$3.22M

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 12.58%
3 Industrials 10.34%
4 Healthcare 9.4%
5 Consumer Discretionary 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BUD icon
2876
AB InBev
BUD
$159B
$3K ﹤0.01%
31
– –
DES icon
2877
WisdomTree US SmallCap Dividend Fund
DES
$2.22B
$3K ﹤0.01%
129
+3
+2% +$81
DLN icon
2878
WisdomTree US LargeCap Dividend Fund
DLN
$6.41B
$3K ﹤0.01%
76
– –
EES icon
2879
WisdomTree US SmallCap Earnings Fund
EES
$730M
$3K ﹤0.01%
115
+1
+0.9% +$32
FLGT icon
2880
Fulgent Genetics
FLGT
$526M
$3K ﹤0.01%
+310
New +$3.67K
NL icon
2881
NLI Holdings
NL
$312M
$3K ﹤0.01%
+532
New +$3.59K
PZA icon
2882
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.26B
$3K ﹤0.01%
150
– –
RCKT icon
2883
Rocket Pharmaceuticals
RCKT
$376M
$3K ﹤0.01%
+340
New +$2.29K
TPST icon
2884
Tempest Therapeutics
TPST
$16.9M
$3K ﹤0.01%
+1
New +$4.66K
VEU icon
2885
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
$3K ﹤0.01%
79
-60
-43% -$2.8K
VTVT icon
2886
vTv Therapeutics
VTVT
$135M
$3K ﹤0.01%
+13
New +$2.96K
ASXC
2887
DELISTED
Asensus Surgical, Inc.
ASXC
$3K ﹤0.01%
+198
New +$3.43K
TTOO
2888
DELISTED
T2 Biosystems, Inc
TTOO
– –
0
– –
EIGR
2889
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3K ﹤0.01%
+9
New +$3.1K
NOVN
2890
DELISTED
Novan, Inc. Common Stock
NOVN
$3K ﹤0.01%
+42
New +$4.38K
AGRX
2891
DELISTED
Agile Therapeutics
AGRX
– –
0
– –
NH
2892
DELISTED
NantHealth, Inc
NH
$3K ﹤0.01%
+37
New +$4.12K
AMPE
2893
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$3K ﹤0.01%
+11
New +$2.96K
KDMN
2894
DELISTED
Kadmon Holdings, Inc.
KDMN
$3K ﹤0.01%
+755
New +$3.05K
SHOS
2895
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
$3K ﹤0.01%
+877
New +$3.31K
ERN
2896
DELISTED
Erin Energy Corp
ERN
$3K ﹤0.01%
+1,082
New +$3.46K
CFNB
2897
DELISTED
California First National Banc
CFNB
$3K ﹤0.01%
+183
New +$2.91K
AST
2898
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$3K ﹤0.01%
+815
New +$3.17K
CIX icon
2899
Comp X International
CIX
$374M
$2K ﹤0.01%
+124
New +$1.77K
CRDF icon
2900
Cardiff Oncology
CRDF
$77.8M
$2K ﹤0.01%
+26
New +$3.53K
114 115
116
117 118

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Ameritas Investment Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Ameritas Investment Partners held 2,969 positions worth $2.02B, up 1.6% from $1.99B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ameritas Investment Partners withdrew a net $130M in Q1 2017, closing 23 positions and reducing 681 holdings. Its most notable exit was Vanguard Total Bond Market, an estimated $34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Bioverativ Inc. Common Stock worth $2.4M.

  • Ameritas Investment Partners's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 44,128 shares worth $2.4M.
  • Ameritas Investment Partners added most to State Street Health Care Select Sector SPDR ETF in Q1 2017, an estimated $2.78M increase.
  • Ameritas Investment Partners's biggest Q1 2017 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $61.8M.
  • Ameritas Investment Partners fully exited Vanguard Total Bond Market in Q1 2017, selling an estimated $34M.
  • Ameritas Investment Partners's ten largest holdings make up 16% of its $2.02B portfolio in Q1 2017.
  • Ameritas Investment Partners opened 1,707 new positions and closed 23 in Q1 2017.
  • Ameritas Investment Partners's portfolio value rose 1.6% quarter-over-quarter to $2.02B.

Based on Ameritas Investment Partners's 13F filing for Q1 2017, filed 9 May 2017.